id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2016-0008-0004,DEA,DEA-2016-0008,Schedules of Controlled Substances: Placement of Brivaracetam into Schedule V,Rule,,2017-03-09T05:00:00Z,2017,3,2017-03-09T05:00:00Z,,2017-03-09T14:59:57Z,2017-04698,0,0,09000064824fb4ab